tradingkey.logo
๎™
๎™ผ
tradingkey.logo
๎™

STAAR Surgical Co

STAA
17.890USD
-0.750-4.02%
์ข…๊ฐ€ย 03/27, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
651.61M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
๎™

์ž์„ธํ•œ ๋‚ด์šฉ์€ STAAR Surgical Co ํšŒ์‚ฌ

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Companyโ€™s principal products are ICLs used in refractive surgery, including its EVO family of lenses.

STAAR Surgical Co ์ •๋ณด

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ STAA
ํšŒ์‚ฌ ์ด๋ฆ„STAAR Surgical Co
์ƒ์žฅ์ผFeb 24, 1992
CEOFarrell (Stephen C)
์ง์› ์ˆ˜1157
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒFeb 24
์ฃผ์†Œ1911 Walker Ave
๋„์‹œMONROVIA
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐ€United States of America
์šฐํŽธ ๋ฒˆํ˜ธ91016
์ „ํ™”16263037902
์›น์‚ฌ์ดํŠธhttps://www.staar.com/
์ข…๋ชฉ ์ฝ”๋“œ STAA
์ƒ์žฅ์ผFeb 24, 1992
CEOFarrell (Stephen C)

STAAR Surgical Co์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
67.50K
+31.06%
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
56.81K
+66.01%
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
25.00K
+60.96%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
8.19K
-31.95%
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
--
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
67.50K
+31.06%
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
56.81K
+66.01%
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
25.00K
+60.96%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
8.19K
-31.95%

์ˆ˜์ต ๋ถ„์„

ํ†ตํ™”: USD๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Tue, Jan 6
ํ†ตํ™”: USD๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
์ง€์—ญ๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
China
55.83M
58.94%
Others
22.04M
23.27%
Japan
11.23M
11.85%
U. S.
5.63M
5.95%
์‚ฌ์—…๋ณ„
์ง€์—ญ๋ณ„
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ๋ณด์œ  ํ†ต๊ณ„

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Feb 21
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Feb 21
์ฃผ์ฃผ
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Broadwood Capital, Inc.
32.56%
BlackRock Institutional Trust Company, N.A.
13.51%
The Vanguard Group, Inc.
8.52%
Yunqi Capital Limited
6.58%
Magnetar Capital Partners LP
4.99%
๊ธฐํƒ€
33.83%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Broadwood Capital, Inc.
32.56%
BlackRock Institutional Trust Company, N.A.
13.51%
The Vanguard Group, Inc.
8.52%
Yunqi Capital Limited
6.58%
Magnetar Capital Partners LP
4.99%
๊ธฐํƒ€
33.83%
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
๋น„์œจ
Hedge Fund
48.53%
Investment Advisor
32.89%
Investment Advisor/Hedge Fund
21.25%
Research Firm
6.25%
Pension Fund
1.05%
Individual Investor
0.64%
Bank and Trust
0.38%
Venture Capital
0.07%
Insurance Company
0.04%

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Thu, Jan 1
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Thu, Jan 1
๋ณด๊ณ  ๊ธฐ๊ฐ„
๊ธฐ๊ด€ ์ˆ˜
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
2025Q4
536
52.38M
105.30%
-16.01M
2025Q3
511
49.83M
100.45%
-14.96M
2025Q2
543
53.99M
109.59%
-5.64M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
2023Q3
658
55.47M
114.38%
-3.16M
๋” ๋ณด๊ธฐ

์ฃผ์ฃผ ํ™œ๋™

๎™Œ
์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
Chg %
๋‚ ์งœ
Broadwood Capital, Inc.
15.02M
30.19%
--
--
Dec 15, 2025
BlackRock Institutional Trust Company, N.A.
6.58M
13.23%
-133.07K
-1.98%
Sep 30, 2025
The Vanguard Group, Inc.
4.26M
8.56%
-121.64K
-2.78%
Sep 30, 2025
Yunqi Capital Limited
2.50M
5.03%
--
--
Dec 10, 2025
Magnetar Capital Partners LP
1.20M
2.42%
+1.20M
--
Sep 30, 2025
Goldman Sachs & Company, Inc.
863.00K
1.74%
+745.45K
+634.18%
Sep 30, 2025
State Street Investment Management (US)
1.91M
3.84%
-91.94K
-4.59%
Sep 30, 2025
Balyasny Asset Management LP
1.81M
3.65%
+1.81M
--
Sep 30, 2025
Geode Capital Management, L.L.C.
1.17M
2.36%
-19.00K
-1.59%
Sep 30, 2025
AQR Capital Management, LLC
645.62K
1.3%
+645.62K
--
Sep 30, 2025
๋” ๋ณด๊ธฐ

๊ด€๋ จ ETF

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
์ด๋ฆ„
๋น„์œจ
AltShares Merger Arbitrage ETF
2.71%
ProShares Merger ETF
2.53%
State Street SPDR S&P Health Care Equipment ETF
1.67%
NYLI Merger Arbitrage ETF
0.87%
Invesco S&P SmallCap Health Care ETF
0.79%
Royce Quant Small-Cap Quality Value ETF
0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
0.13%
iShares S&P Small-Cap 600 Growth ETF
0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
0.1%
iShares ESG Select Screened S&P Small-Cap ETF
0.1%
๋” ๋ณด๊ธฐ
AltShares Merger Arbitrage ETF
๋น„์œจ2.71%
ProShares Merger ETF
๋น„์œจ2.53%
State Street SPDR S&P Health Care Equipment ETF
๋น„์œจ1.67%
NYLI Merger Arbitrage ETF
๋น„์œจ0.87%
Invesco S&P SmallCap Health Care ETF
๋น„์œจ0.79%
Royce Quant Small-Cap Quality Value ETF
๋น„์œจ0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
๋น„์œจ0.13%
iShares S&P Small-Cap 600 Growth ETF
๋น„์œจ0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
๋น„์œจ0.1%
iShares ESG Select Screened S&P Small-Cap ETF
๋น„์œจ0.1%

์ฃผ์‹ ๋ฐฐ๋‹น๊ธˆ

๎™Œ
์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ด 0.00 USD์˜ ๋ฐฐ๋‹น๊ธˆ์ด ๋ถ„๋ฐฐ๋˜์—ˆ์Šต๋‹ˆ๋‹ค.
๋‚ ์งœ
๋ฐฐ๋‹น๊ธˆ
๊ธฐ์ค€์ผ
์ง€๊ธ‰์ผ
๋ฐฐ๋‹น๋ฝ์ผ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ถ„ํ• 

๎™Œ
๋‚ ์งœ
๋ฐฐ๋‹น๋ฝ์ผ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
๋‚ ์งœ
๋ฐฐ๋‹น๋ฝ์ผ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
KeyAI
๎™